Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum
Authors:
- Mark Johan SchuuringMSMark Johan Schuuring
- Roderick Willem TreskesRTRoderick Willem Treskes
- Ruben Casado-ArroyoRCRuben Casado-Arroyo
- Lis NeubeckLNLis Neubeck
- Alexander R LyonALAlexander R Lyon
- Nurgul KeserNKNurgul Keser
- Marcin RucinskiMRMarcin Rucinski
- Maria MarketouMaria Marketou
- Ekaterini LambrinouELEkaterini Lambrinou
- Maurizio VolterraniMVMaurizio Volterrani
Open Access
- 30 August 2024
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 5 (6) , 670-682
Abstract
The 2021 European Society of Cardiology guideline on diagnosis and treatment of acute and chronic heart failure (HF) and the 2023 Focused Update include recommendations on the pharmacotherapy for patients with New York Heart Association (NYHA) class II–IV HF with reduced ejection fraction. However, multinational data from the EVOLUTION HF study found substantial prescribing inertia of guideline-directed medical therapy (GDMT) in clinical practice. The cause was multifactorial and included limitations in organizational resources. Digital solutions like digital consultation, digital remote monitoring, digital interrogation of cardiac implantable electronic devices, clinical decision support systems, and multifaceted interventions are increasingly available worldwide. The objectives of this Clinical Consensus Statement are to provide (i) examples of digital solutions that can aid the optimization of prescription of GDMT, (ii) evidence-based insights on the optimization of prescription of GDMT using digital solutions, (iii) current evidence gaps and implementation barriers that limit the adoption of digital solutions in clinical practice, and (iv) critically discuss strategies to achieve equality of access, with reference to patient subgroups. Embracing digital solutions through the use of digital consults and digital remote monitoring will future-proof, for example alerts to clinicians, informing them of patients on suboptimal GDMT. Researchers should consider employing multifaceted digital solutions to optimize effectiveness and use study designs that fit the unique sociotechnical aspects of digital solutions. Artificial intelligence solutions can handle larger data sets and relieve medical professionals’ workloads, but as the data on the use of artificial intelligence in HF are limited, further investigation is warranted.Keywords
This publication has 142 references indexed in Scilit:
- Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021JAMA Cardiology, 2024
- Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the USJAMA Cardiology, 2023
- Frailty Interferes with the Guideline-Directed Medical Therapy in Heart Failure Patients with Reduced Ejection FractionESC Heart Failure, 2022
- Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart FailureJAMA Cardiology, 2022
- Digital Health in Older Adults for the Prevention and Management of Cardiovascular Diseases and Frailty. A Clinical Consensus Statement from the ESC Council for Cardiology Practice/Taskforce on Geriatric Cardiology, the ESC Digital Health Committee and the ESC Working Group on e-CardiologyESC Heart Failure, 2022
- Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure—Optimizing Therapy With the Need for SpeedJAMA Cardiology, 2021
- Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the USJAMA Network Open, 2021
- Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection FractionJAMA Cardiology, 2020
- Effectiveness of Sacubitril–Valsartan in Cancer Patients with Heart FailureESC Heart Failure, 2020
- Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart FailureJAMA, 2019